- Molecular Templates Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 15, 2023
- G1 Therapeutics Inc, Molecular Templates Inc, Olema Pharmaceuticals Inc and Puma Biotechnology Inc at Cowen Health Care Conference- Panel TranscriptMar 07, 2023
- Molecular Templates Inc at Piper Sandler Healthcare Conference TranscriptDec 01, 2022
- Molecular Templates Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 30, 2022
- Molecular Templates Inc To Present Interim Data and Host R&D Day at The Society for Immunotherapy of Cancer's (SITC) 37th Annual Meeting TranscriptNov 11, 2022
- Molecular Templates Inc To Discuss Unique Approach To Immuno-Oncology For Solid Tumors Call TranscriptApr 13, 2022
- Molecular Templates Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) TranscriptSep 20, 2021
- Molecular Templates Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 10, 2021
- Molecular Templates Inc To Discuss The Use of Egineer Toxin Bodies (EBTs) TranscriptSep 29, 2020
- Molecular Templates Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- Molecular Templates Inc at UBS Global Healthcare Conference (Virtual) TranscriptMay 18, 2020
- Molecular Templates Inc R&D Day TranscriptNov 15, 2019
- Molecular Templates Inc at UBS Global Healthcare Conference TranscriptMay 20, 2019
Molecular Templates Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Okay. Great. Thank you. My name is Frank Brisebois. I'm one of the biotech analysts here at Oppenheimer. Thanks for joining us on day three of the conference. Even if I know everyone's been fairly extremely busy with the fund markets these days.
So with that, thank you very much, Eric, for taking the time here. So we'll have -- the next company presenting is Molecular Templates. And we'll have Eric Poma. He's the CEO of the company to present. And then if we have a little time at the end, we're going throw in some Q&A. So feel free to hit the icon on your window and send in some questions. I'll try my best to get to them. But we'll get right to it here.
Eric, thanks for joining. I'll let you take it away.
Great, man. Thanks for a great conference and for letting us have the opportunity to present. I'll make forward-looking statements here. But for those of you who don't know, we've been working, at Molecular
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)